Mesa Historical Cash Flow
| MLAB Stock | USD 118.35 1.90 1.63% |
Analysis of Mesa Laboratories cash flow over time is an excellent tool to project Mesa Laboratories future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 17.4 M or Depreciation of 33.2 M as it is a great indicator of Mesa Laboratories ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Mesa Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mesa Laboratories is a good buy for the upcoming year.
Mesa |
About Mesa Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Mesa balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Mesa's non-liquid assets can be easily converted into cash.
Mesa Laboratories Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Mesa Laboratories' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Mesa Laboratories current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.At present, Mesa Laboratories' Change To Inventory is projected to decrease significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 43.6 M, whereas Change In Cash is projected to grow to (4.5 M).
Mesa Laboratories cash flow statement Correlations
Click cells to compare fundamentals
Mesa Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mesa Laboratories cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 414K | 929K | (1.0M) | (10.2M) | 2.6M | 2.7M | |
| Change In Cash | 71.2M | 182.5M | (214.5M) | (16.4M) | (4.7M) | (4.5M) | |
| Free Cash Flow | 25.1M | 35.1M | 34.8M | 23.4M | 41.6M | 43.6M | |
| Change In Working Capital | (3.1M) | 5.3M | (7.2M) | (17.1M) | 6.0M | 6.3M | |
| Begin Period Cash Flow | 10.2M | 81.4M | 263.9M | 49.3M | 32.9M | 17.4M | |
| Other Cashflows From Financing Activities | (5.4M) | 3.5M | 76.9M | 6.1M | (1.2M) | (1.2M) | |
| Depreciation | 13.0M | 17.7M | 25.1M | 33.8M | 31.6M | 33.2M | |
| Other Non Cash Items | 11.8M | 5.1M | 8.0M | 1.3M | 277.3M | 291.2M | |
| Capital Expenditures | 1.5M | 2.0M | 4.4M | 4.5M | 2.6M | 1.8M | |
| Total Cash From Operating Activities | 26.6M | 37.1M | 39.2M | 28.0M | 44.1M | 46.3M | |
| Net Income | 1.3M | 3.3M | 1.9M | 930K | (254.2M) | (241.5M) | |
| Total Cash From Financing Activities | 231.3M | 146.2M | 52.6M | (33.3M) | 32.8M | 34.5M | |
| End Period Cash Flow | 81.4M | 263.9M | 49.3M | 32.9M | 28.2M | 18.0M | |
| Sale Purchase Of Stock | 177.4M | 150.4M | (875K) | 7.0M | (728K) | (691.6K) | |
| Change To Liabilities | (2.2M) | 650K | 4.0M | (4.9M) | (4.4M) | (4.2M) | |
| Change To Account Receivables | (1.7M) | (647K) | (6.8M) | (2.1M) | 4.9M | 5.2M | |
| Dividends Paid | 2.7M | 3.2M | 3.3M | 3.4M | 3.4M | 2.3M | |
| Total Cashflows From Investing Activities | (185.6M) | (2.0M) | (305.2M) | (9.5M) | (8.5M) | (9.0M) | |
| Stock Based Compensation | 5.5M | 9.3M | 11.4M | 12.5M | 11.9M | 22.1M | |
| Other Cashflows From Investing Activities | (14.4M) | (2.6M) | (184.1M) | (5.0M) | (4.5M) | (4.7M) | |
| Change Receivables | 1.6M | (1.7M) | (647K) | (2.1M) | (1.9M) | (1.8M) | |
| Net Borrowings | 144.1M | (664K) | 49M | (36M) | (41.4M) | (39.3M) | |
| Cash And Cash Equivalents Changes | 4.7M | 71.2M | 181.3M | (14.8M) | (17.1M) | (16.2M) | |
| Cash Flows Other Operating | 4.6M | 10.1M | 7.2M | 1.0M | 923.4K | 877.2K | |
| Change To Netincome | 6.9M | 11.3M | 19.5M | 10.3M | 11.9M | 12.5M | |
| Change To Operating Activities | (2.6M) | 2.6M | (3.4M) | (3.9M) | (3.5M) | (3.3M) | |
| Investments | (185.6M) | (2.0M) | (305.2M) | (9.5M) | (81.3M) | (85.4M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (45.62) | Revenue Per Share 42.3 | Quarterly Revenue Growth 0.088 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.